Valued at $67.0M at its early-stage round, Jun 2025. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch Syntis Bio: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Syntis Bio funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Early Stage VC | $25.0M | ▮ | ▮ |
| Dec 2024 | Early Stage VC | $6.3M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $15.4M | ▮ | ▮ |
Membership and data by Private Market View
Syntis Bio valuation
Syntis Bio was valued at $67 million at its early-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Syntis Bio raised?
Syntis Bio has raised $48.4 million across 3 recorded rounds since 2022. The largest was a $6.3 million early-stage round in Dec 2024; the most recent was a $25 million early-stage round in Jun 2025.
Syntis Bio has filed 4 Form Ds with the SEC since 2022, most recently in Jul 2025 ($25 million sold to 12 investors).
How Syntis Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Syntis Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Syntis Bio
- What is Syntis Bio worth?
- Syntis Bio is valued at $67.0M as of Oct 2026. Valued at $67.0M at its early-stage round, Jun 2025. Nothing has traded since.
- How much has Syntis Bio raised?
- Syntis Bio has raised $48.4M in total funding across 3 recorded rounds.
- When did Syntis Bio last raise?
- Syntis Bio last raised in Jun 2025 (Early Stage VC), raising $25.0M.